Normal levels of testosterone may be achievable with hormone therapy and lifestyle adjustments. It’s okay for testosterone levels to fluctuate for women in different stages of life. While it’s known that many men with low testosterone levels, often referred to as T levels, can be asymptomatic, the effects of low testosterone in women are not as well studied. Many women with high testosterone levels will have irregular menses or no period at all. Methyltestosterone is an oral androgen modified at the 17-alpha position resulting in decreased first pass hepatic clearance and is approved in the US for treatment of testosterone deficiency. It is possible that exercise programs coupled with diet may have a greater likelihood of success in achieving increases in total testosterone over calorie-restricted diets alone. Across all studies, men had a mean baseline testosterone of 323 ng/dL, mean age of 59.9 years, and were followed for an average 34 weeks, during which time they were administered either a placebo or one of several testosterone modalities. A discussion regarding the benefit of stopping testosterone therapy should include the possibility of a decline in PSA. PSA recurrence in men on testosterone therapy should be evaluated in the same fashion as untreated men. There are limited data in men on active surveillance who are candidates for testosterone therapy. Six patients experienced biochemical recurrence, all of whom had intermediate- or high-risk prostate cancer. The general trend indicated that higher doses of testosterone were more likely to result in azoospermia than lower doses, however a dose-response effect was not consistently seen. The trials were not powered to measure MACE as a primary endpoint (outcome measures included efficacy or product, muscle strength, AMS scores, and sex drive); cardiac-related events were categorized as adverse outcomes. There were inconsistently defined end points to categorize severe cardiac events, which included 'softer' endpoints (e.g., edema, tachycardia, hypertension) along with myocardial infarction and stroke.194 The statistical analysis did not account for confounding factors; the duration of follow-up varied widely, from 12 weeks to 3 years; and many of the trials were not powered to detect cardiac events as primary endpoints, rather they were catalogued as adverse outcomes. Thresholds for low testosterone were not universal. One RCT by Maggi et al. followed 715 testosterone deficient men for 12 weeks to evaluate the effects of a 2% transdermal testosterone agent on sex drive and energy. All patients had PSA and digital rectal exams every three months and biopsies annually. If the testosterone concentration is increased further, rather than further proliferation, the cells reduce their rate of proliferation.343, 344 This phenomenon is known as the bipolar testosterone concept. I've seen significant improvements in my energy levels, mood, and overall well-being. Schedule a video consultation with a licensed provider who will personalize your treatment based on your health goals. Men and women have different physiologic ranges, different evidence bases for treatment, and different monitoring goals. Supraphysiologic levels may increase adverse effects without improving the intended therapeutic outcome. Your testosterone levels will go back down between doses. The authors conducted a retrospective analysis of 6,355 Medicare beneficiaries who had at least 1 testosterone injection (mean number of injections over the entire study period 8.2) and matched them to 19,065 men who were testosterone therapy naïve for the preceding 12 months. Despite the homogenous nature of the trials included, it was noted that there was a risk of publication bias since it is possible that trials favoring testosterone therapy might remain unpublished. Transgender and transmasculine folks looking to achieve and sustain certain changes often use testosterone therapy long term. If a woman has symptoms of high or low testosterone, it’s recommended that she visit a healthcare provider to get further testing and a diagnosis. Despite the lack of targeted therapies for women with low testosterone, they have one option that may increase their levels. "By the time a woman reaches 40, testosterone blood levels have declined significantly," Dr. Dorr says. If a woman is experiencing symptoms of too much testosterone, it’s best to seek treatment to find the underlying cause. High levels of testosterone in females may indicate polycystic ovary syndrome (PCOS), adrenal tumors, ovarian tumors, or hermaphroditism (having both female and male sex organs). Both males and females produce testosterone in their bodies, but males typically have much higher levels of it.
